ibandronic acid has been researched along with Alloxan Diabetes in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, CQ; Jin, HF; Liu, XW; Tang, LJ | 1 |
| Iacobellis, G | 1 |
2 other study(ies) available for ibandronic acid and Alloxan Diabetes
| Article | Year |
|---|---|
Farnesyl Pyrophosphate Synthase Blocker Ibandronate Reduces Thoracic Aortic Fibrosis in Diabetic Rats.
Topics: Animals; Aorta, Thoracic; Aortic Diseases; Diabetes Mellitus, Experimental; Fibrosis; Geranyltranstransferase; Hypoglycemic Agents; Ibandronic Acid; Male; Rats; Rats, Sprague-Dawley | 2019 |
Treating the Bone to Protect the Heart: Potential Newer Mechanisms and Targets.
Topics: Animals; Diabetes Mellitus, Experimental; Fibrosis; Heart; Ibandronic Acid; Polyisoprenyl Phosphates; Rats; Sesquiterpenes | 2019 |